P555: Systematic review of interventions for chronic abdominal pain management in inflammatory bowel diseaseECCO '17 Barcelona
2017
P556: Female Crohn's disease patients and ulcerative colitis patients on biologic therapy are most disabledECCO '17 Barcelona
2017
P557: Utility of “trough levels” adalimumab determination in patients with inflammatory bowel disease. Estimation of individual pharmacokinetic parameters through population pharmacokinetic modelECCO '17 Barcelona
2017
P558: The SF-36® Health Survey distinguishes disease burden on functioning and well-being between patients with active vs inactive ulcerative colitisECCO '17 Barcelona
2017
P560: Trough levels at induction: impact on long term response when re-initiating infliximabECCO '17 Barcelona
2017
P562: Real-life infliximab trough levels among inflammatory bowel disease patients on maintenance therapy: should we redefine therapeutic range based on inflammatory load?ECCO '17 Barcelona
2017
P563: Psychotherapy experience and demand for it and their association in inflammatory bowel disease – results from an internet-based surveyECCO '17 Barcelona
2017
P564: Low-dose azathioprine improves long-term efficacy of infliximab maintenance treatment in Japanese patients with Crohn's diseaseECCO '17 Barcelona
2017
P565: Assessments of clinical efficacy and mucosal healing in ulcerative colitis patients undergoing granulomonocytapheresis at different treatment frequenciesECCO '17 Barcelona
2017
P566: Frequency and type of drug-related side effects necessitating drug cessation in the Swiss inflammatory bowel disease cohortECCO '17 Barcelona
2017
P567: Cross-sectional study of the low serum concentrations of testosterone in IBD and the influence on disease activityECCO '17 Barcelona
2017
P568: Does infliximab therapy increase incidence of tuberculosis in patients with inflammatory bowel disease in an endemic area: a nationwide study from ChinaECCO '17 Barcelona
2017
P569: Sequential rescue treatments in steroid refractory ulcerative colitis: two-year follow-upECCO '17 Barcelona
2017
P570: Current status of the effectiveness of infliximab in patients with ulcerative colitisECCO '17 Barcelona
2017
P572: Medical therapies for stricturing Crohn's disease: efficacy and cross-sectional imaging predictors of therapeutic failureECCO '17 Barcelona
2017